
Yara Abdou, MD, looks back on what have been the biggest challenges in treating HER2-positive breast cancer over the past 5-10 years.
Yara Abdou, MD, is an assistant professor of medicine at the University of North Carolina School of Medicine and specializes in the treatment of early stage and metastatic breast cancer.